DIN 02504022 — SANDOZ OSELTAMIVIR 75 MG
SANDOZ OSELTAMIVIR is a capsule of Oseltamivir marketed by SANDOZ CANADA INCORPORATED. The full Oseltamivir monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02504022
- Brand name
- SANDOZ OSELTAMIVIR
- Active ingredient
- Oseltamivir
- Strength
- 75 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- SANDOZ CANADA INCORPORATED
- Health Canada status
- MARKETED
- Drug class
- Neuraminidase inhibitor (antiviral agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Oseltamivir products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02497409 | JAMP OSELTAMIVIR | 30 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED |
| 02497425 | JAMP OSELTAMIVIR | 75 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED |
| 02497441 | MINT-OSELTAMIVIR | 30 MG | CAPSULE | MINT PHARMACEUTICALS INC | MARKETED |
| 02497476 | MINT-OSELTAMIVIR | 75 MG | CAPSULE | MINT PHARMACEUTICALS INC | MARKETED |
| 02472635 | NAT-OSELTAMIVIR | 30 MG | CAPSULE | NATCO PHARMA (CANADA) INC | MARKETED |
| 02472643 | NAT-OSELTAMIVIR | 45 MG | CAPSULE | NATCO PHARMA (CANADA) INC | MARKETED |
| 02499894 | NAT-OSELTAMIVIR | 6 MG | POWDER FOR SUSPENSION | NATCO PHARMA (CANADA) INC | MARKETED |
| 02457989 | NAT-OSELTAMIVIR | 75 MG | CAPSULE | NATCO PHARMA (CANADA) INC | MARKETED |
| 02504006 | SANDOZ OSELTAMIVIR | 30 MG | CAPSULE | SANDOZ CANADA INCORPORATED | MARKETED |
| 02504014 | SANDOZ OSELTAMIVIR | 45 MG | CAPSULE | SANDOZ CANADA INCORPORATED | MARKETED |
| 02304848 | TAMIFLU | 30 MG | CAPSULE | HOFFMANN-LA ROCHE LIMITED | MARKETED |
| 02304856 | TAMIFLU | 45 MG | CAPSULE | HOFFMANN-LA ROCHE LIMITED | MARKETED |
| 02381842 | TAMIFLU | 6 MG | POWDER FOR SUSPENSION | HOFFMANN-LA ROCHE LIMITED | MARKETED |
| 02241472 | TAMIFLU | 75 MG | CAPSULE | HOFFMANN-LA ROCHE LIMITED | MARKETED |